Andreas Koeberle
Impact in
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 56
- Inflammatory mediators and NSAID effects 37
- Toxicology 10
- Bioactive Compounds and Antitumor Agents 10
- Co-authors
- Oliver WerzHinnak NorthoffStefan LauferAntonietta RossiLidia SautebinCarlo PergolaSolveigh C. KoeberleTakao Shimizu
In The Last Decade
Andreas Koeberle
133 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 136
- Pharmacology 1.6k
- Biochemistry 503
- Toxicology 233
- Biochemistry 216
- Pharmacology 313
Countries citing papers authored by Andreas Koeberle
This map shows the geographic impact of Andreas Koeberle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Koeberle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Koeberle more than expected).
Fields of papers citing papers by Andreas Koeberle
This network shows the impact of papers produced by Andreas Koeberle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Koeberle. The network helps show where Andreas Koeberle may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Koeberle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 65 | |
| 6 | 2023 | 52 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 40 | |
| 12 | 2021 | 30 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 63 | |
| 15 | 2019 | 34 | |
| 16 | 2018 | 24 | |
| 17 | 2017 | 1 | |
| 18 | 2017 | 76 | |
| 19 | 2016 | 24 | |
| 20 | 2015 | 29 |
About Andreas Koeberle
Andreas Koeberle is a scholar working on Pharmacology, Toxicology, Biochemistry, Cancer Research and Aging, having authored 134 papers that have together received 4.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (37 papers), Natural product bioactivities and synthesis (16 papers), Estrogen and related hormone effects (14 papers), Bioactive Compounds and Antitumor Agents (10 papers), Cancer, Lipids, and Metabolism (10 papers), Synthesis and biological activity (9 papers), Fatty Acid Research and Health (8 papers) and Lipid metabolism and biosynthesis (8 papers). The work is most often cited by research in Pharmacology (1.6k citations), Biochemistry (503 citations), Toxicology (233 citations), Biochemistry (216 citations) and Pharmacology (313 citations). Andreas Koeberle has collaborated with scholars based in Germany, Austria and Italy. Frequent co-authors include Oliver Werz, Hinnak Northoff, Stefan Laufer, Antonietta Rossi, Lidia Sautebin, Carlo Pergola, Solveigh C. Koeberle, Takao Shimizu, Hideo Shindou and Friederike Dehm. Their work appears in journals such as The FASEB Journal, British Journal of Pharmacology, Journal of Medicinal Chemistry, Biochemical Pharmacology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.